Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical trial NCT03917472 · COMPLETED
Trial details
- NCT number
- NCT03917472
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2021-03-24
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.